Trademark: 97130054
Status Date
Tuesday, December 12, 2023
Filing Date
Wednesday, November 17, 2021
Published for Opposition
Tuesday, October 17, 2023
5 diagnostic assays and reagents for clinical and medical use, namely for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely cancers
44 medical testing and diagnostic services, namely, testing for medical diagnostic or treatment purposes in the field of cancer, autoimmune disease, maternal fetal medicine; clinical pathology services, namely, medical testing for diagnostic or treatment purposes in the field of clinical pathology; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services
10 testing instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the field of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic testing kits consisting primarily of probes, buffer, and reagent for use in microbial testing
Feb 6, 2024
Teas Change Of Correspondence Received
Feb 6, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 6, 2024
Teas Change Of Owner Address Received
Dec 12, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 17, 2023
Published For Opposition
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
Sep 8, 2023
Approved For Pub - Principal Register
Sep 8, 2023
Teas/Email Correspondence Entered
Sep 8, 2023
Correspondence Received In Law Office
Sep 8, 2023
Examiner's Amendment Entered
Sep 8, 2023
Notification Of Examiners Amendment E-Mailed
Sep 8, 2023
Examiners Amendment E-Mailed
Sep 8, 2023
Examiners Amendment -Written
Jun 23, 2023
Teas Response To Suspension Inquiry Received
Mar 9, 2023
Notification Of Letter Of Suspension E-Mailed
Mar 9, 2023
Letter Of Suspension E-Mailed
Mar 9, 2023
Suspension Letter Written
Mar 1, 2023
Teas/Email Correspondence Entered
Feb 28, 2023
Correspondence Received In Law Office
Feb 28, 2023
Teas Response To Office Action Received
Feb 8, 2023
Automatic Update Of Assignment Of Ownership
Aug 29, 2022
Notification Of Non-Final Action E-Mailed
Aug 29, 2022
Non-Final Action E-Mailed
Aug 29, 2022
Non-Final Action Written
Aug 29, 2022
Assigned To Examiner
Nov 23, 2021
New Application Office Supplied Data Entered
Nov 20, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
